| scholarly article | Q13442814 |
| P50 | author | Laura Peña | Q63369322 |
| P2093 | author name string | M Clemente | |
| P Cuesta | |||
| M D Pérez-Alenza | |||
| P J De Andrés | |||
| P2860 | cites work | Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years | Q24680218 |
| Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles | Q28144551 | ||
| Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002) | Q28283951 | ||
| Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up | Q28306437 | ||
| Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry | Q33527137 | ||
| Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates | Q33595267 | ||
| Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification. | Q42439751 | ||
| Expression and prognostic significance of CK19 in canine malignant mammary tumours | Q42450410 | ||
| Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade | Q44457905 | ||
| Clinicopathological survey of 101 canine mammary gland tumors: differences between small-breed dogs and others | Q44852242 | ||
| Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. | Q44855446 | ||
| COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers | Q46991225 | ||
| Statistical analysis regarding the effects of height and weight on life span of the domestic dog. | Q47324957 | ||
| Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. | Q47771117 | ||
| Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors | Q47984572 | ||
| Classification and grading of canine mammary tumors. | Q51512956 | ||
| Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms. | Q51528964 | ||
| Metastasis of canine inflammatory versus non-inflammatory mammary tumours. | Q51568873 | ||
| Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. | Q51588287 | ||
| The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours. | Q51601413 | ||
| Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. | Q51619031 | ||
| E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables. | Q51814819 | ||
| Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. | Q53560179 | ||
| Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology | Q57438097 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 94-105 | |
| P577 | publication date | 2012-06-11 | |
| P1433 | published in | Veterinary Pathology | Q7923710 |
| P1476 | title | Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics | |
| P478 | volume | 50 |
| Q99605126 | A Statistical Analysis of Risk Factors and Biological Behavior in Canine Mammary Tumors: A Multicenter Study |
| Q36265702 | A first immunohistochemistry study of transketolase and transketolase-like 1 expression in canine hyperplastic and neoplastic mammary lesions. |
| Q86838793 | A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours |
| Q53073419 | Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study. |
| Q36811022 | Breed- and age-related differences in canine mammary tumors |
| Q35587062 | Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN |
| Q46271916 | Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors |
| Q40034698 | Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time |
| Q42454727 | Cellular sources of tenascin-C in canine mammary carcinomas. |
| Q96762430 | Chemokine gene expression influences metastasis and survival time of female dogs with mammary carcinoma |
| Q36247593 | Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index |
| Q37315632 | Clinical staging in bitches with mammary tumors: Influence of type and histological grade |
| Q52558390 | Clinicopathological Diversity of Canine Mammary Gland Tumors in Sri Lanka: A One-Year Survey on Cases Presented to Two Veterinary Practices. |
| Q64245103 | Detection and Prognostic Relevance of Circulating and Disseminated Tumour Cell in Dogs with Metastatic Mammary Carcinoma: A Pilot Study |
| Q48184289 | Diagnostic efficacy of smear cytology and Robinson's cytological grading of canine mammary tumors with respect to histopathology, cytomorphometry, metastases and overall survival. |
| Q42452843 | Differences in indicators of malignancy between luminal epithelial cell type and myoepithelial cell type of simple solid carcinoma in the canine mammary gland. |
| Q46887796 | Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer |
| Q99555975 | Discrimination of Benign and Malignant Lesions in Canine Mammary Tissue Samples Using Raman Spectroscopy: A Pilot Study |
| Q37020475 | Effect of Ovariohysterectomy at the Time of Tumor Removal in Dogs with Mammary Carcinomas: A Randomized Controlled Trial |
| Q42376186 | Evaluation of expression of the Wnt signaling components in canine mammary tumors via RT2 Profiler PCR Array and immunochemistry assays. |
| Q34669271 | Gene expression profiles in canine mammary carcinomas of various grades of malignancy |
| Q91968762 | Global gene expression profile in canine mammary carcinomas |
| Q104691641 | HSP110 expression in canine mammary gland tumor and its correlation with histopathological classification and grade |
| Q33880705 | Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma. |
| Q47666371 | Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland. |
| Q101136575 | Increased programmed death ligand (PD-L1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) expression is associated with metastasis and poor prognosis in malignant canine mammary gland tumours |
| Q53104819 | Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis. |
| Q92542968 | Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors |
| Q39207451 | Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas |
| Q51060593 | Obesity, expression of adipocytokines, and macrophage infiltration in canine mammary tumors. |
| Q53272410 | Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs. |
| Q38792187 | Profile of Steroid Receptors and Increased Aromatase Immunoexpression in Canine Inflammatory Mammary Cancer as a Potential Therapeutic Target |
| Q38205199 | Prognostic evaluation of feline mammary carcinomas: a review of the literature. |
| Q64276401 | Prognostic value of fluorine flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma |
| Q44477076 | Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis |
| Q91587636 | Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas |
| Q46540170 | Proposed classification of the feline "complex" mammary tumors as ductal and intraductal papillary mammary tumors |
| Q89717933 | Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors: Comparison with immunohistochemistry analysis |
| Q90584116 | Role of body condition score and adiponectin expression in the progression of canine mammary carcinomas |
| Q38303454 | The importance of comparative oncology in translational medicine |
| Q47572448 | Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors |
| Q92624799 | Whole-exome and whole-transcriptome sequencing of canine mammary gland tumors |
Search more.